High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study
<p>Abstract</p> <p>Background</p> <p>Background rates of latent tuberculosis infection in low prevalence regions of Britain are unknown. These would be valuable data for interpreting positive IGRA results, and guiding cost-benefit analyses. The management of a large out...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-12-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-2334/12/339 |
| _version_ | 1818158009736495104 |
|---|---|
| author | Hinks Timothy SC Varsani Nimu Godsiff David T Bull Thomas C Nash Katherine L McLuckie Lisa Maule Catherine Flower Tessa Warley Anthony |
| author_facet | Hinks Timothy SC Varsani Nimu Godsiff David T Bull Thomas C Nash Katherine L McLuckie Lisa Maule Catherine Flower Tessa Warley Anthony |
| author_sort | Hinks Timothy SC |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Background rates of latent tuberculosis infection in low prevalence regions of Britain are unknown. These would be valuable data for interpreting positive IGRA results, and guiding cost-benefit analyses. The management of a large outbreak of tuberculosis occurring in a rural district hospital provided an opportunity to determine the background rates and epidemiology of IGRA-positivity amongst unselected hospital patients in a low-prevalence region of U.K.</p> <p>Methods</p> <p>As part of a public health surveillance project we identified 445 individuals exposed to the index cases for clinical assessment and testing by a TB-specific interferon-γ release assay (IGRA): T-Spot.<it>TB</it>. Uniquely, an additional comparator group of 191 age-matched individuals without specific recent exposure, but with a similar age distribution and demographic, were recruited from the same wards where exposure had previously occurred, to undergo assessment by questionnaire and IGRA<it>.</it></p> <p>Results</p> <p>Rates of IGRA positivity were 8.7% (95%CI, 4.2-13, <it>n</it>=149) amongst unexposed patients, 9.5%(3.0-22, <it>n</it>=21) amongst unexposed staff, 22%(14–29, <it>n</it>=130) amongst exposed patients, 11%(6.1-16, <it>n</it>=142) amongst exposed staff. Amongst the individuals without history of recent exposure to the outbreak, IGRA-positivity was associated with prior TB treatment (OR11, P.04) and corticosteroid use (OR5.9, P.02). Background age-specific prevalences of IGRA-positivity amongst unexposed individuals were: age <40 0%(N/A), age 40–59 15%(12–29), age 60–79 7.0%(1.1-13), age≥80 10%(5.9-19).</p> <p>Conclusions</p> <p>Background rates of IGRA-positivity remain high amongst unselected white-Caucasian hospital inpatients in U.K. These data will aid interpretation of future outbreak studies. As rates peak in the 5<sup>th</sup> and 6<sup>th</sup> decade, given an ageing population and increasing iatrogenic immunosuppression, reactivation of LTBI may be a persistent hazard in this population for several decades to come.</p> |
| first_indexed | 2024-12-11T15:23:17Z |
| format | Article |
| id | doaj.art-bf4b09ce91e5424c8cbd803c8fcb9f94 |
| institution | Directory Open Access Journal |
| issn | 1471-2334 |
| language | English |
| last_indexed | 2024-12-11T15:23:17Z |
| publishDate | 2012-12-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Infectious Diseases |
| spelling | doaj.art-bf4b09ce91e5424c8cbd803c8fcb9f942022-12-22T01:00:18ZengBMCBMC Infectious Diseases1471-23342012-12-0112133910.1186/1471-2334-12-339High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance studyHinks Timothy SCVarsani NimuGodsiff David TBull Thomas CNash Katherine LMcLuckie LisaMaule CatherineFlower TessaWarley Anthony<p>Abstract</p> <p>Background</p> <p>Background rates of latent tuberculosis infection in low prevalence regions of Britain are unknown. These would be valuable data for interpreting positive IGRA results, and guiding cost-benefit analyses. The management of a large outbreak of tuberculosis occurring in a rural district hospital provided an opportunity to determine the background rates and epidemiology of IGRA-positivity amongst unselected hospital patients in a low-prevalence region of U.K.</p> <p>Methods</p> <p>As part of a public health surveillance project we identified 445 individuals exposed to the index cases for clinical assessment and testing by a TB-specific interferon-γ release assay (IGRA): T-Spot.<it>TB</it>. Uniquely, an additional comparator group of 191 age-matched individuals without specific recent exposure, but with a similar age distribution and demographic, were recruited from the same wards where exposure had previously occurred, to undergo assessment by questionnaire and IGRA<it>.</it></p> <p>Results</p> <p>Rates of IGRA positivity were 8.7% (95%CI, 4.2-13, <it>n</it>=149) amongst unexposed patients, 9.5%(3.0-22, <it>n</it>=21) amongst unexposed staff, 22%(14–29, <it>n</it>=130) amongst exposed patients, 11%(6.1-16, <it>n</it>=142) amongst exposed staff. Amongst the individuals without history of recent exposure to the outbreak, IGRA-positivity was associated with prior TB treatment (OR11, P.04) and corticosteroid use (OR5.9, P.02). Background age-specific prevalences of IGRA-positivity amongst unexposed individuals were: age <40 0%(N/A), age 40–59 15%(12–29), age 60–79 7.0%(1.1-13), age≥80 10%(5.9-19).</p> <p>Conclusions</p> <p>Background rates of IGRA-positivity remain high amongst unselected white-Caucasian hospital inpatients in U.K. These data will aid interpretation of future outbreak studies. As rates peak in the 5<sup>th</sup> and 6<sup>th</sup> decade, given an ageing population and increasing iatrogenic immunosuppression, reactivation of LTBI may be a persistent hazard in this population for several decades to come.</p>http://www.biomedcentral.com/1471-2334/12/339TuberculosisDiagnosisMycobacteriumT-Spot.<it>TB</it>Enzyme-linked immunospot |
| spellingShingle | Hinks Timothy SC Varsani Nimu Godsiff David T Bull Thomas C Nash Katherine L McLuckie Lisa Maule Catherine Flower Tessa Warley Anthony High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study BMC Infectious Diseases Tuberculosis Diagnosis Mycobacterium T-Spot.<it>TB</it> Enzyme-linked immunospot |
| title | High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study |
| title_full | High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study |
| title_fullStr | High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study |
| title_full_unstemmed | High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study |
| title_short | High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study |
| title_sort | high background rates of positive tuberculosis specific interferon γ release assays in a low prevalence region of uk a surveillance study |
| topic | Tuberculosis Diagnosis Mycobacterium T-Spot.<it>TB</it> Enzyme-linked immunospot |
| url | http://www.biomedcentral.com/1471-2334/12/339 |
| work_keys_str_mv | AT hinkstimothysc highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy AT varsaninimu highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy AT godsiffdavidt highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy AT bullthomasc highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy AT nashkatherinel highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy AT mcluckielisa highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy AT maulecatherine highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy AT flowertessa highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy AT warleyanthony highbackgroundratesofpositivetuberculosisspecificinterferongreleaseassaysinalowprevalenceregionofukasurveillancestudy |